Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_assertion type Assertion NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_head.
- NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_assertion description "[Here, we discovered that carriers of both variants, AKAP10 Ile646Val and AKAP13 Lys526Gln, are at a further enhanced breast cancer risk (OR=2.41, 95% CI 1.30-4.46, P=0.005).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_provenance.
- NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_assertion evidence source_evidence_literature NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_provenance.
- NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_assertion SIO_000772 16956908 NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_provenance.
- NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_assertion wasDerivedFrom gad-20150221 NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_provenance.
- NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_assertion wasGeneratedBy ECO_0000203 NP102500.RAfz5m2lUuj9Rxy0ZXFRboPRT0_RU4antli21ENKHi4Jg130_provenance.